Ohio State Navbar

Directory

Anil K. Agarwal, MD


Staff photo

395 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-4997

Email: agarwal.8@osu.edu

 

Current OSU Appointments

Professor-Clinical, Nephrology

Physician, FGP-Nephrology

 

Licenses

present Medical License: State Medical Board of Ohio
1980 - present Board Certified in Internal Medicine in India: MLB Medical College
1995 - present Diplomat: American Board of Internal Medicine
1996 - present Diplomat: American Board of Nephrology
 

Chapters in Books

-.

ASSESSMENT OF RENAL-FUNCTION

Cystic Disease of the Kidney

Updates in Nephrology

Clinical Assessment of Renal Function

Cystic disease of the kidney.

Metabolic acidosis.

Progression of Kidney Disease: Diagnosis and Management

Future Directions in Management of Anemia in Heart Failure

ESA Therapy and Renal and Non-Renal Outcomes

Cystic Diseases of the Kidney

Kidney Stones

Metabolic Acidosis and Alkalosis

Hemodialysis Access

Accessory veins

Certification and accreditation in Interventional Nephrology

Establishing vascular access centers

Types of vascular access, characteristics and epidemiology

Central Vein Stenosis

Techniques for peritoneal dialysis catheter placement and maintenance

 

Clinical Services

04/01/1983 - 06/01/1992 Solo Practice in Internal Medicine (Meerut, India)

Degrees

1983 M.D., MLB Medical College

 

Edited Books

Textbook of Nephrology for the Asian Pacific Physicians

NephSAP: Vascular Access for Dialysis

Heart Failure Clinics of North America: Anemia and Heart Failure

 

Editorial Activities

2000 - present Southerm Medical Journal
2001 - present American Journal of Kidney Disease
2003 - present Journal of American Society of Nephrology
2003 - 2008 Prescriber's Letter - Editorial Advisory Board
2004 Nephron
2004 - 2008 Special Review Panel for the Self-Assessment Questions in Neph SAP published by American Society of Nephrology
2005 Clinical Nephrology
2005 Annals of Internal Medicine
2007 - present Kidney International
2007 - present Seminars in Dialysis
2007 Vascular Health and Risk Management (International Society of Vascular Health)
2007 Pediatric Nephrology
2008 - present The Open Urology Nephrology Journal published by Benthan Publishers
2008 - present The Open Urology and Nephrology Journal published by Benthan Publishers
2009 - present Seminars in Dialysis
2009 - present National Institutes of Health
2009 - present The Open Urology Nephrology Journal published by Bentham Publishers
2009 Nephron
2009 Libertas Academica, New Zealand
2009 Lancet
2009 Journal of Critical Care Medicine
2009 BioMed Central Nephrology
2009 Annals of Saudi Medicine
2009 Advances in Chronic Kidney Disease
2010 - present Internet Journal of Nephrology
2010 Annals of Internal Medicine
2011 - present World Journal of Nephrology
2011 - present American Heart Journal
2011 - present Kidney Research UK's External Referee Panel
2011 - present Hemodialysis International
2011 Peritoneal Dialysis
2011 Clinical and Applied Thrombosis/Hemostasis
2011 Clinical Anatomy
2013 - present KRND ESRD/Dialysis Review Group
2013 - present American Journal of Nephrology
 

Honors

present Fellow. National Kidney Foundation.
present Fellow. American Society of Nephrology.
present Fellow. American College of Physicians.
present Obstetrics and Gynecology. MLB Medical College, Jhansi, India.
present Social and Preventive Medicine. MLB Medical College, Jhansi, India.
present Forensic Medicine. MLB Medical College, Jhansi, India.
1972 - 1979 National Merit Scholarship.
2007 Best Doctors in America. US News & World Report.
2008 Best Doctors in America. US News & World Report.
2009 Best Doctors in America. US News & World Report.
2010 Best Doctors in America. US News & World Report.
2010 Top Doctor in Columbus, Ohio. International Association of Internists.
2011 Platinum Award. Clayton Taylor Dialysis Unit.
2011 Best Doctors in America. US News & World Report.
2012 Teacher of the Year. Division of Nephrology.
2012 Best Doctors in America. US News & World Report.
2013 National Kidney Foundation Champion. National Kidney Foundation.
2013 Best Doctors in America. US News & World Report.
 

Journal Articles

 

Reference Works

January 1995 Agarwal AK, Cosio FG, Roche Z, Falkenhain ME, Ferguson RM."Prevalence of Hepatitis C Antibodies in Patients with Glomerulonephritis of Native and Transplant Kidneys" . : 410A
January 1995 A Agarwal, FG Cosio, Z Roche, ME Falkenhain, RM Ferguson."Prevalence of Hepatitis C antibodies in patients with glomerulonephritis of native and transplant kidneys" . : 410A
January 1996 Ladson-Wofford SE, Agarwal G, Agarwal AK, Reif M, Hebert LA."Relationship Between Socioeconomic Status and Nocturnal Blood Pressure in Treated Hypertensive African-Americans Compared to Treated Hypertensive European Americans" . : 1552A
January 1996 SE Ladson-Wofford, G Agarwal, A Agarwal, M Reif, LA Hebert."Relationship between socioeconomic status and nocturnal blood pressure in treated hypertensive African-Americans compared to treated hypertensive European-Americans" . : 1552A
January 1998 Agarwal AK, Agarwal G, Bay WH, Middendorf DM, Ladson-Wofford SE, Fromkes J, Sundaram U, Hebert LA."Unexplained Nausea in ESRD Patients is Usually a Manifestation of Acid Peptic Disease" . : 241A
January 1998 AK Agarwal, G Agarwal, WH Bay, DM Middendorf, SE Ladson-Wofford, J Fromkes, U Sundaram, LA Hebert."Unexplained nausea in ESRD patients is usually a manifestation of acid peptic disease" . : 241A
January 1998 Agarwal AK, Thomas AJ."Male Infertility in Autosomal Dominant Polycystic Kidney Disease due to Ductal Obstruction from Dilatation of Seminal Vesicles" . : 370A
January 1998 AK Agarwal, AJ Thomas."Male infertility in autosomal dominant polycystic kidney disease due to ductal obstruction from dilatation of seminal vesicles" . : 370A
January 1999 AK Agarwal, WH Bay, FG Cosio, SS VanCleef, LA Hebert."Seasonal variation in incidence of infection in long term tunneled catheters (LTTC) and Gore-Tex grafts (GG) used as hemodialysis vascular access (HVA)" . : 200A
January 2000 AK Agarwal, G Agarwal, SS VanCleef, FG Cosio."Shunt survival in hemodialysis patients depends upon cardiac function" . : 179A
January 2003 A Agra, AK Agarwal."Hemodialysis as an alternative to Charcoal Hemoperfusion for treatment of acute Carbamazepine toxicity" . : 817A
January 2003 Ayran MD, Wilmer WA, Falkenhain M, Agarwal AK, Magro CA."Painless Ischemic Myopathy of Calciphylaxis" .
January 2003 MD Ayran, WA Wilmer, MA Falkenhain, AK Agarwal, CA Magro."Painless ischemic myopathy of calciphylaxis" . : 787A
January 2003 M Walczyk, A Agarwal, B Ling, W Carroll, W Liu, R Brenner."Aranesp (Darbepoetin Alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease" . : 770A
January 2003 Agra A, Agarwal AK."Hemodialysis as an Alternative to Charcoal Hemoperfusion for Treatment of Acute Carbamazepine Toxicity" .
January 2004 Agarwal AK, Spetie D."Declining utilization of peritoneal dialysis in a large academic clinical nephrology program" . : 811A
January 2004 A Agarwal, B Ling, M Walczyk, W Carroll, W Liu, R Brenner."Aranesp (Darbepoetin Alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease (CKD)" . : A15
January 2004 LA Hebert, T Nadasdy, G Agarwal, M Mauer, AK Agarwal, G Nadasdy, DN Spetie, NS Nahman."Proposed diagnostic criteria and classification of Loin Pain Hematuria Syndrome (LPHS) based on kidney biopsy in 83 patients" . : 117A
January 2004 N Mittman, F Finkelstein, B Culleton, C Charytan, A Agarwal, MA Albizem, MG Guo, PS Klassen, SM Sprague."Cinacalcet HCl (Sensipar) for the management of secondary hyperparathyroidism (HPT) in patients receiving peritoneal dialysis (PD)" . : 280A
January 2004 Agarwal AK, Patel BM, Farhan NJ."Central venous stenosis in hemodialysis patients is a common complication of ipsilateral central vein catheterization" . : 368A
January 2005 Farhan N, Rajan J, Agarwal A, Hebert L."ACE Inhibitors suppress plasma aldosterone better than Angiotensin Receptor Blockers in chronic kidney disease" . : 616A
January 2005 Agarwal AK, Agarwal G, Seth S, Hartman J, Spetie D, Hebert LA."Chronic daily intravenous Sodium Thiosulphate therapy does not consistently alter pain or narcotic use in loin pain hematuria syndrome (LPHS)" . : 781A
January 2005 Silver MR, Agarwal AK, Walczyk MH, Fadda G, Varma N, Liu W, Stehman-Breen, C."De novo every-other-week (Q2W) Aranesp (Darbepoetin Alfa) dosing in patients with chronic kidney disease (CKD) not receiving dialysis" . : 762A
January 2005 J Hertel, H Locay, D Scarlata et al including A Agarwal as part of the STAAR Study Group."Every-other-week Aranesp (Darbepoetin Alfa) achieves and maintains target hemoglobin levels and improves health-related quality of life in recombinant human erythropoietin naïve patients with chronic kidney disease" .
January 2005 Biyyani RS, Burdge K and Agarwal AK."Bisphosphonate therapy: A rare cause of hyperphosphatemia" . : 906A
January 2006 Nadasdy T, Nadasdy G, Agarwal G, et al, including Agarwal A."Idiopathic thick basement membrane nephropathy: A newly recognized cause of glomerular hematuria" . : 258A
January 2006 AK Agarwal, A Patnaik, AK Mandal, HN Nagaraja."Cross Sectional Measurements of Blood Glucose and Blood Pressure Correlate Highly with Outcomes in Diabetic Asian Indian Patients" . : 909A
January 2007 Parikh SV, Brown CG, Haddad N,et al including A Agarwal."Prevalence of Central Venous Stenosis with Internal Jugular Dialysis Catheters in End Stage Renal Disease Patients" . : 268A
January 2007 Agarwal A."De novo every−other−week (Q2W) Darbepoetin Alfa treatment corrects and maintains hemoglobin levels in patients with chronic kidney disease" . : 758A
January 2007 Mandal A, Patnaik A, Agarwal A, Nagaraja A."Effect of antihypertensive therapy on renal function in Asian Indian Diabetic patients" . : 847A
January 2007 A. K. Mandal, A. Patnaik, A. K. Agarwal, H. N. Nagaraja."Effect of blood glucose and blood pressure control on renal function in Asian Indian diabetic patients with chronic kidney disease" .
January 2007 Kashyap R, Waheed U, Brown C, et al including A Agarwal."Pacemaker Associated Central Venous Stenosis in Hemodialysis Patients: Incidence and Outcomes" . : 267A
January 2008 Brenner L, Bolton WK, Agarwal A, Bender J, Coyne D."Theoretical Safety Concerns with Anemia Therapies: Results Following Ferumoxytol and Oral Iron Treatment in CKD Patients" . : 730A
January 2008 Zakaria S, Habib P, Valentine C, Shidham G, Agarwal A."An unusual cause of malignant hypertension" . : B84
January 2008 Kharat V, VanCleef S, Hiremath L, Haddad N, Brown C, Agarwal A."Does Vein Mapping Change Access Placement Rates?" . : 259A
January 2009 Kharat V, VanCleef S, Hiremath L, Haddad N, Brown C, Agarwal A."Does Vein Mapping Change Access Placement Rates?" .
January 2009 Haykal MK, Abdelhadi NA, Rahman MA, Agarwal A, Nkruma M, Ahmed S, Mohammad YM."The Migraine- Blood Pressure Connection: Solving the Puzzle" .
January 2009 Agarwal A, Kewalramani R, Droge J, Huang F, McClellan W."Hemoglobin variability in subjects with chronic kidney disease not receiving dialysis : An analysis of Darbepoetin Alfa clinical trial data" . : A23
January 2010 Samavedi S, Parikh S, Gunay Y, Agarwal A, Von Visger J, Nori U, Pesavento T, Henry M, Singh N."Impact Of Post Kidney Transplant Parathyroidectomy On Early Graft Function" .
January 2010 Shah R, Van Cleef, S, Bhatt U, Davis A, Ross M, Swope M, Agarwal A."Impact of missing hemodialysis sessions on arteriovenous access thrombosis" .
January 2010 Nijmeh R, Parikh S, Timmerman S, Bhatt U, Agarwal A."Citrate Vs Heparin lock: Comparing catheter outcomes for short-term inpatient hemodialysis" .
January 2012 McNeely J, Parikh S, Valentine C, Haddad N, Shidham G, Rovin B, Hebert L, Agarwal A."American Society of Nephrology, San Diego, 2012" .
Provenzano R, Hulter H, Agarwal A, Klaus S, Lee T, Yu P, Neff T."Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor FG-2216 increases Hb without Fe depletion in the absence of IV Fe" .
Kayi P, Van Cleef S, Shah R, Agarwal A."Routine Pre-Procedural Labs for Outpatient Interventional Nephrology procedures - Utility and Impact" .

Presentations

Declining incidence of spinal epidural abscess in a large chronic hemodialysis program

Aranesp (Darbepoetin Alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease (CKD)

Darbepoetin alfa administered once monthly maintains hemoglobin in CKD patients

Bisphosphonate Therapy: A Rare Cause of Hyperphosphatemia

On behalf of the STAAR study group Darbepoetin Alfa administered every other week (Q2W) corrects and maintains hemoglobin in chronic kidney disease patients

Retropharyngeal abscess: A rare complication of line related bacteremia in a patient with ESRD

Cross Sectional Measurements of Blood Glucose and Blood Pressure Correlate Highly with Outcomes in Diabetic Asian Indian Patients

Once-Monthly (QM) Aranesp® (Darbepoetin alfa) Maintains Target Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD)

Once-Monthly (QM) Aranesp® (Darbepoetin alfa) Maintains Target Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD)

Once-monthly (QM) Darbepoetin alfa effectively maintains hemoglobin levels in older patients with chronic kidney disease

Once-Monthly (QM) Aranesp® (Darbepoetin alfa) Maintains Target Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD)

Iatrogenic fistula formation between Arteriovenous graft and adjacent vein. Poster Presentation

Effect of baseline estimated glomerular filtration rate on the efficacy of once-monthly Darbepoetin alfa in the maintenance of hemoglobin levels in patients with chronic kidney disease

The Effect of Baseline Estimated Glomerular Filtration Rate (eGFR) on Hemoglobin (Hb) Response within the first 12 Weeks after Converting to Once-Monthly (QM) Darbepoetin Alfa Treatment in Patients with Chronic Kidney Disease

Is Online Access Flow Measurement as Accurate as Doppler Flow in Predicting Need for Access Intervention in Dialysis Patients?

Internal Jugular dialysis catheters are associated with high incidence of central vein stenosis in end stage renal disease patients

De novo Darbepoetin alfa Administered Every Other Week (Q2W) Corrects and Maintains Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease

De novo every other week (Q2W) Darbepoetin alfa used to correct hemoglobin levels in older chronic kidney disease subjects naïve to erythropoiesis stimulating protein treatment

Internal Jugular dialysis catheters are associated with high incidence of central vein stenosis in end stage renal disease patients

Central venous stenosis in Systemic Lupus Erythematous Associated ESRD

Analysis of the dose relationship between Epoetin alfa and Darbepoetin alfa in patients with chronic kidney disease not on dialysis

Analysis of the dose relationship between recombinant human erythropoietin and darbepoetin alfa in elderly patients with chronic kidney disease not on dialysis

Relationship between socioeconomic status (SS) and nocturnal blood pressure in treated hypertensive African-Americans (AA) compared to treated hypertensive European-Americans (EA).

 

Professional Activities

2000 - present Ad Hoc Member, Renal Advisory Committee. Abbott Laboratories.
2002 - present Ad Hoc Member, Advisory Board. Novartis Pharmaceuticals.
2002 - present Ad Hoc Member, Advisory Board. Amgen, Inc..
2007 - present Member. National Kidney Foundation of Ohio.
1986 - 1989 Medical Consultant. Fertilizer Corporation of India.
1985 - 1990 Medical Consultant. State Bank of India.
1985 - 1992 Medical Consultant. Life Insurance Corporation of India.
2004 Nephrology Key Opinion Leader Group. Shire Pharmaceuticals.